Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Atorvastatin Versus Rosuvastatin on LV Function and Inflammatory Biomarkers in Type 2 Diabetic Patients With Dyslipidemia

NCT03784703 is registered in ClinicalTrials.gov with Damanhour University as lead sponsor.

NCT NCT03784703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03784703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Atorvastatin Versus Rosuvastatin on LV Function and Inflammatory Biomarkers in Type 2 Diabetic Patients With Dyslipidemia
Lead sponsor
Damanhour University
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2018
Completion date
January 31, 2020
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia associated with type ii diabetes mellitus